Standardized methodology for transfemoral transcatheter aortic valve replacement with the Edwards Sapien XT valve under fluoroscopy guidance

Journal of Invasive Cardiology

Volumn 26, Issue 9, 2014, Pages 451-461

  Kasel, Albert M ^a,b   Shivaraju, Anupama ^a,b   Schneider, Stephan ^a   Krapf, Stephan ^a   Oertel, Frank ^a   Burgdorf, Christof ^b   Ott, Ilka ^b   Sumer, Christian ^a   Kastrati, Adnan ^b   Von Scheidt, Wolfgang ^a   Thilo, Christian ^a  

^a KLINIKUM AUGSBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

aortic valve stenosis; procedure methodology; transfemoral TAVR

Indexed keywords

ANALGESIC AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGED; AORTA ROOT; AORTA STENOSIS; ARTERY OCCLUSION; ARTICLE; BLOOD VESSEL OCCLUSION; CARDIAC PATIENT; CEREBELLUM INFARCTION; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHY SCANNER; CONSCIOUS SEDATION; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY OCCLUSION; COST EFFECTIVENESS ANALYSIS; FALSE ANEURYSM; FEMALE; FLUOROSCOPY; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART TAMPONADE; HIGH RISK PATIENT; HUMAN; INGUINAL HEMATOMA; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MULTIPLE ORGAN FAILURE; OPERATION DURATION; PATIENT SAFETY; PERCUTANEOUS AORTIC VALVE; POSTOPERATIVE HEMORRHAGE; STANDARDIZATION; SURGICAL MORTALITY; SURGICAL PATIENT; SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSIENT ISCHEMIC ATTACK; TRANSTHORACIC ECHOCARDIOGRAPHY; VASCULAR DISEASE; ANGIOGRAPHY; AORTA VALVE; AORTIC VALVE STENOSIS; CLASSIFICATION; ECHOCARDIOGRAPHY; FEMORAL ARTERY; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; RADIOGRAPHY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STANDARDS; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANALGESICS; ANGIOGRAPHY; AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; CONSCIOUS SEDATION; ECHOCARDIOGRAPHY; FEMALE; FEMORAL ARTERY; FLUOROSCOPY; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, SPIRAL COMPUTED; TREATMENT OUTCOME;

EID: 84907045694     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Vahanian A, Alfieri O, Andreotti F, et al; ESC Committee for Practice Guidelines (CPG); Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012;42(4):S1-44.
2. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231-1243.
3. Choong CK, Sergeant P, Nashef SA, Smith JA, Bridgewater B. The Euroscore risk stratification system in the current era: how accurate is it and what should be done if it is inaccurate? Eur J Cardiothorac Surg. 2009;35(1):59-61.
4. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106(24):3006-3008.
5. Thomas M, Schymik G, Walther T, et al. One-year outcomes of cohort 1 in the Edwards Sapien Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards Sapien valve. Circulation. 2011;124(4):425-433.
6. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116(7):755-763.
7. Zahn R, Gerckens U, Grube E, et al; German Transcatheter Aortic Valve Interventions-Registry I. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J. 2011;32(2):198-204.
8. Kodali SK, Williams MR, Smith CR, et al; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366(18):1686-1695.
9. Licker M, Schweizer A, Ellenberger C, Tschopp JM, Diaper J, Clergue F. Perioperative medical management of patients with copd. Int J Chron Obstruct Pulmon Dis. 2007;2(4):493-515.
10. Durand E, Borz B, Godin M, et al. Transfemoral aortic valve replacement with the Edwards Sapien and Edwards Sapien XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. JACC Cardiovasc Interv. 2012;5(5):461-467.
11. Greif M, Lange P, Nabauer M, et al. Transcutaneous aortic valve replacement with the Edwards Sapien XT and Medtronic CoreValve prosthesis under fluoroscopic guidance and local anaesthesia only. Heart. 2014;100(9):691-695 (Epub 2014 Jan 23).
12. Kasel AM, Cassese S, Bleiziffer S, et al. Standardized imaging for aortic annular sizing: implications for transcatheter valve selection. JACC Cardiovasc Imaging. 2013;6(2):249-262.
13. Kasel AM, Cassese S, Leber AW, von Scheidt W, Kastrati A. Fluoroscopy-guided aortic root imaging for TAVR: "follow the right cusp" rule. JACC Cardiovasc Imaging. 2013;6(2):274-275.
14. Kappetein AP, Head SJ, Genereux P, et al; Valve Academic Research Consortium-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg. 2012;42(5):S45-S60.
15. Sandler H, Dodge HT, Hay RE, Rackley CE. Quantitation of valvular insufficiency in man by angiocardiography. Am Heart J. 1963;65:501-513.
16. Sinning JM, Hammerstingl C, Vasa-Nicotera M, et al. Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;59(13):1134-1141.
17. Thilo C, Maurer CJ, Berlis A, von Scheidt W, Kasel AM. Successful management of cerebral embolism during TAVR. Clin Res Cardiol. 2014;103(4):329-331 (Epub 2014 Jan 8).
18. Cribier A. Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey. Arch Cardiovasc Dis. 2012;105(3):146-152.
19. Ben-Dor I, Looser PM, Maluenda G, et al. Transcatheter aortic valve replacement under monitored anesthesia care versus general anesthesia with intubation. Cardiovasc Revasc Med. 2012;13(4):207-210.
20. Binder RK, Webb JG, Willson AB, et al. The impact of integration of a multidetector computed tomography annulus area sizing algorithm on outcomes of transcatheter aortic valve replacement: a prospective, multicenter, controlled trial. J Am Coll Cardiol. 2013;62(5):431-438.
21. Becker DE, Haas DA. Management of complications during moderate and deep sedation: respiratory and cardiovascular considerations. Anesth Prog. 2007;54(2):59-68; quiz 69.
22. Makkar RR, Fontana GP, Jilaihawi H, et al; the PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366(18):1696-1704.
23. Abdel-Wahab M, Zahn R, Horack M, et al, German Transcatheter Aortic Valve Interventions Registry. Aortic regurgitation after transcatheter aortic valve implantation: Incidence and early outcome. Results from the german transcatheter aortic valve interventions registry. Heart. 2011;97(11):899-906.
24. Schultz C, Rossi A, van Mieghem N, et al. Aortic annulus dimensions and leaflet calcification from contrast MSCT predict the need for balloon post-dilatation after tavi with the medtronic corevalve prosthesis. EuroIntervention. 2011;7(5):564-572.
25. Nombela-Franco L, Rodes-Cabau J, DeLarochelliere R, et al. Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv. 2012;5(5):499-512.
26. Kahlert P, Knipp SC, Schlamann M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010;121(7):870-878.
27. Eggebrecht H, Schmermund A, Voigtlander T, Kahlert P, Erbel R, Mehta RH. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention. 2012;8(1):129-138.
28. Leon MB, Smith CR, Mack M, et al; The PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597-1607.
29. Smith CR, Leon MB, Mack MJ, et al; The PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187-2198.
30. Erkapic D, De Rosa S, Kelava A, Lehmann R, Fichtlscherer S, Hohnloser SH. Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol. 2012;23(4):391-397.
31. Bates MG, Matthews IG, Fazal IA, Turley AJ. Postoperative permanent pacemaker implantation in patients undergoing transcatheter aortic valve implantation: what is the incidence and are there any predicting factors? Interact Cardiovasc Thorac Surg. 2011;12(2):243-253.
32. Huynh H, Dalloul G, Ghanbari H, et al. Permanent pacemaker implantation following aortic valve replacement: current prevalence and clinical predictors. Pacing Clin Electrophysiol. 2009;32(12):1520-1525.
33. Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the choice randomized clinical trial. JAMA. 2014;311(15):1503-1514.
34. El-Khally Z, Thibault B, Staniloae C, et al. Prognostic significance of newly acquired bundle branch block after aortic valve replacement. Am J Cardiol. 2004;94(8):1008-1011.
35. Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34(29):2281-2329 (Epub 2013 Jun 24).
36. Khawaja MZ, Rajani R, Cook A, et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation. 2011;123(9):951-960.
37. Griese DP, Reents W, Diegeler A, Kerber S, Babin-Ebell J. Simple, effective and safe vascular access site closure with the double-Proglide preclose technique in 162 patients receiving transfemoral transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2013;82(5):E734-E741.
38. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the Sapien Aortic Bioprosthesis European Outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards Sapien valve. Circulation. 2010;122(1):62-69.